Kai Guo

902 total citations · 1 hit paper
38 papers, 666 citations indexed

About

Kai Guo is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Kai Guo has authored 38 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Biomedical Engineering, 12 papers in Molecular Biology and 10 papers in Biomaterials. Recurrent topics in Kai Guo's work include Nanoplatforms for cancer theranostics (17 papers), Nanoparticle-Based Drug Delivery (8 papers) and Ferroptosis and cancer prognosis (5 papers). Kai Guo is often cited by papers focused on Nanoplatforms for cancer theranostics (17 papers), Nanoparticle-Based Drug Delivery (8 papers) and Ferroptosis and cancer prognosis (5 papers). Kai Guo collaborates with scholars based in China, United States and Singapore. Kai Guo's co-authors include Quazi T.H. Shubhra, Yixuan Liu, Min Ding, Haibo Wang, Di Zhang, Haodong Cui, Chengfei Zhang, Nanyang Xiao, Jingqian Su and A.K.M. Moshiul Alam and has published in prestigious journals such as SHILAP Revista de lepidopterología, The EMBO Journal and ACS Nano.

In The Last Decade

Kai Guo

35 papers receiving 659 citations

Hit Papers

Disulfidptosis classification of hepatocellular carcinoma... 2023 2026 2024 2025 2023 25 50 75

Peers

Kai Guo
Qian Wen China
Emanuela Gentile United States
Kai Guo
Citations per year, relative to Kai Guo Kai Guo (= 1×) peers Paras Famta

Countries citing papers authored by Kai Guo

Since Specialization
Citations

This map shows the geographic impact of Kai Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Guo more than expected).

Fields of papers citing papers by Kai Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Guo. The network helps show where Kai Guo may publish in the future.

Co-authorship network of co-authors of Kai Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Guo. A scholar is included among the top collaborators of Kai Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Guo. Kai Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Hui, Mengyao Mu, Yuan Gao, et al.. (2025). Photothermal-Triggered Radical Storm for Achieving Multi-Layered PD-L1 Inhibition in Cancer Theranostics. Chemical Engineering Journal. 513. 162636–162636. 1 indexed citations
2.
Kho, Ay Lin, Christoph S. Clemen, Rolf Schröder, et al.. (2025). The deubiquitinase USP5 prevents accumulation of protein aggregates in cardiomyocytes. Science Advances. 11(4). eado3852–eado3852. 2 indexed citations
3.
Wang, Chenyu, Mengyao Mu, Ke Ren, et al.. (2025). Convertible ROS Nanocatalyst/Eliminator for Enhancing Tumor Radio‐Immunotherapy and Relieving Radiation Enteritis. Advanced Science. 12(33). e03602–e03602.
4.
Guo, Kai, Lu Han, Xin Shun Ding, et al.. (2025). The tryptophan metabolite indole 3-propionic acid alleviates lung ischemia–reperfusion injury via prostaglandin reductase 2 in male mice. Biochemical Pharmacology. 242(Pt 4). 117427–117427. 1 indexed citations
6.
Zheng, Haoyi, Lifeng Xu, Rong Jin, et al.. (2024). Development a risk prediction nomogram for multidrug−resistant bacterial and fungal infection in gastrointestinal fistula patients during the perioperative period. Frontiers in Cellular and Infection Microbiology. 14. 1502529–1502529.
7.
Guo, Kai, Siyu Cai, Ke Ren, et al.. (2024). Customized Sized Manganese Sulfide Nanospheres as Efficient T 1 MRI Contrast Agents for Enhanced Tumor Theranostics. Biomaterials Research. 28. 116–116. 2 indexed citations
8.
You, Chaoqun, et al.. (2024). Mesenchymal stem cell-derived exosomes as a new drug carrier for the treatment of spinal cord injury: A review. Chinese Journal of Traumatology. 27(3). 134–146. 10 indexed citations
9.
Hou, Bin, et al.. (2024). Tumor-derived exosomal hyaluronidase 1 induced M2 macrophage polarization and promoted esophageal cancer progression. Experimental Cell Research. 439(1). 113963–113963. 7 indexed citations
10.
Mu, Mengyao, Mengmeng Zhang, Kai Guo, et al.. (2024). A multifunctional nanoplatform capable of dual action on tumor PD-L1 for enhanced cancer theranostics. Chemical Engineering Journal. 502. 158139–158139. 1 indexed citations
11.
Gao, Yuan, Mengyao Mu, Wei Yu, et al.. (2024). Novel ultrathin ferrous sulfide nanosheets: Towards replacing black phosphorus in anticancer nanotheranostics. Bioactive Materials. 43. 564–578. 9 indexed citations
12.
Wang, Xinyuan, Huabin Zhang, Yuqin Wang, et al.. (2023). DNA sensing via the cGAS/STING pathway activates the immunoproteasome and adaptive T‐cell immunity. The EMBO Journal. 42(8). e110597–e110597. 34 indexed citations
13.
Guo, Kai, Dong Chen, Shuai Ren, et al.. (2023). Reversing Immune Suppression and Potentiating Photothermal Immunotherapy via Bispecific Immune Checkpoint Inhibitor Loaded Hollow Polydopamine Nanospheres. ACS Applied Materials & Interfaces. 15(11). 13879–13891. 6 indexed citations
15.
Huang, Chong, et al.. (2023). M2 macrophage-derived exosomes carry miR-142-3p to restore the differentiation balance of irradiated BMMSCs by targeting TGF-β1. Molecular and Cellular Biochemistry. 479(4). 993–1010. 8 indexed citations
16.
Guo, Kai, et al.. (2022). CASP6 predicts poor prognosis in glioma and correlates with tumor immune microenvironment. Frontiers in Oncology. 12. 818283–818283. 11 indexed citations
17.
Shubhra, Quazi T.H., et al.. (2021). Dual targeting smart drug delivery system for multimodal synergistic combination cancer therapy with reduced cardiotoxicity. Acta Biomaterialia. 131. 493–507. 48 indexed citations
18.
Zhou, Miao, Shuyi Li, Kausik Kapat, et al.. (2020). Bioinspired channeled, rhBMP-2-coated β-TCP scaffolds with embedded autologous vascular bundles for increased vascularization and osteogenesis of prefabricated tissue-engineered bone. Materials Science and Engineering C. 118. 111389–111389. 12 indexed citations
19.
Su, Jingqian, Kai Guo, Min Huang, et al.. (2019). Fucoxanthin, a Marine Xanthophyll Isolated From Conticribra weissflogii ND-8: Preventive Anti-Inflammatory Effect in a Mouse Model of Sepsis. Frontiers in Pharmacology. 10. 906–906. 66 indexed citations
20.
Han, Lu, Xiao Yang, Haijing Liu, et al.. (2018). Value of time-intensity curve analysis of contrast-enhanced ultrasound in the differential diagnosis of thyroid nodules. European Journal of Radiology. 105. 182–187. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026